RAS mutation specific survival in patients with metastatic colorectal cancer treated with trifluridine/tipiracil

被引：0
|
作者：
Grell, Peter
Batko, Stanislav
Pirsthuk, Alina
Borilova, Simona
Polachova, Katerina
Mazuchova, Blanka
Tomasek, Jiri
Fabian, Pavel
Berkovcova, Jitka
Bardelcik, Miroslav
Obermannova, Radka
Buchler, Tomas
Kiss, Igor
机构：
[1] Masaryk Mem Canc Inst, Brno, Czech Republic
[2] Motol Univ Hosp, Prague, Czech Republic
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
613-135-2370-7650-2700; 3282-206-4957-326-5009-5024-5025; 3282-206-4957-326-5009-2386; 10; 2; 38092-25821; 38092-18412; 38092-18849; 8; 4;
D O I：
10.1200/JCO.2024.42.3_suppl.197
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Post-marketing surveillance study of trifluridine/tipiracil in patients with metastatic colorectal cancer
    Yoshino, Takayuki
    Uetake, Hiroyuki
    Funato, Yuya
    Yamaguchi, Yasunobu
    Koyama, Takahiko
    Ozawa, Daisuke
    Tajiri, Masaru
    Muro, Kei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (05) : 700 - 706
  • [42] Effectiveness and safety of trifluridine/tipiracil in patients with metastatic colorectal cancer in clinical practice in Poland
    Radecka, B.
    Gelej, M.
    Streb, J.
    Siedlaczek, A.
    Kryka, K.
    Tokajuk, P.
    Winsko-Szczesnowicz, K.
    Czernek, U.
    Sobczak, M.
    Malik, M.
    Bodnar, L.
    Foszczynska-Kloda, M.
    Hetman, K.
    Skiewicz, M. Welnicka-Ja
    Wierzbicka, K.
    Orlikowska, M.
    Becht, R.
    Deptala, A.
    Itrych, B.
    Kania-Zembaczynska, B.
    ANNALS OF ONCOLOGY, 2020, 31 : S108 - S108
  • [43] Safety of trifluridine/tipiracil (FTD/TPI) in elderly patients with metastatic colorectal cancer.
    Mayer, Robert J.
    Hochster, Howard S.
    Cohen, Steven J.
    Winkler, Robert
    Makris, Lukas
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [44] Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis
    Basso, Michele
    Signorelli, Carlo
    Calegari, Maria Alessandra
    Lucchetti, Jessica
    Zurlo, Ina Valeria
    Dell'Aquila, Emanuela
    Arrivi, Giulia
    Zoratto, Federica
    Santamaria, Fiorenza
    Saltarelli, Rosa
    Trovato, Giovanni
    Caira, Giulia
    Angotti, Lorenzo
    Schirripa, Marta
    Anghelone, Annunziato
    Schietroma, Francesco
    Chilelli, Mario Giovanni
    Salvatore, Lisa
    Pozzo, Carmelo
    Tortora, Giampaolo
    TARGETED ONCOLOGY, 2024, 19 (03) : 371 - 382
  • [45] QTWiST analysis of the RECOURSE trial of trifluridine/tipiracil in metastatic colorectal cancer
    Tabernero, Josep
    Van Cutsem, Eric
    Ohtsu, Atsushi
    Amellal, Nadia
    Cadour, Stephanie
    Fougeray, Ronan
    Haffemayer, Benjamin
    Mayer, Robert J.
    ESMO OPEN, 2017, 2 (05)
  • [46] Emerging combination therapies for metastatic colorectal cancer - impact of trifluridine/tipiracil
    Puthiamadathil, Jeevan M.
    Weinberg, Benjamin A.
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 461 - 469
  • [47] Trifluridine/tipiracil in metastatic gastric cancer
    McCaw, Zachary R.
    Kim, Dae Hyun
    Tian, Lu
    Fu, Haoda
    Wei, Lee-Jen
    LANCET ONCOLOGY, 2019, 20 (01): : E8 - E8
  • [48] Interpreting the Benefit of Trifluridine/Tipiracil in Metastatic Colorectal Cancer With Respect to Progression-Free Survival and Overall Survival
    Sun, Ryan
    Horiguchi, Miki
    Wei, Lee-Jen
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (13) : 1378 - 1379
  • [49] Metastatic colorectal Carcinoma Trifluridine/Tipiracil improves the Survival and maintains the General Condition
    Ortner, Petra
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (12) : 833 - 833
  • [50] Metastatic colorectal Carcinoma Trifluridine/Tipiracil improves the Survival and maintains the General State
    Ortner, Petra
    VISCERAL MEDICINE, 2016, 32 (06) : 441 - 441
12345